![MorphoSys AG](/common/images/company/N_MOR.png)
MorphoSys AG is a biopharmaceutical company dedicated to the discovery, development and commercialization of therapies for people living with cancer and autoimmune diseases. MorphoSys is advancing its own pipeline of new drug candidates and has created antibodies that are developed by partners in di... MorphoSys AG is a biopharmaceutical company dedicated to the discovery, development and commercialization of therapies for people living with cancer and autoimmune diseases. MorphoSys is advancing its own pipeline of new drug candidates and has created antibodies that are developed by partners in different areas of unmet medical need. Tremfya (guselkumab) - developed by Janssen Research & Development, LLC and marketed by Janssen Biotech, Inc. for the treatment of plaque psoriasis - became the first drug based on MorphoSys antibody technology to receive regulatory approval. The U.S. Food and Drug Administration granted accelerated approval of the company's proprietary product Monjuvi (tafasitamab-cxix) in combination with lenalidomide for patients with a certain type of lymphoma. Show more
JPMorgan Asia Growth & Income PLC 31 July 2024 JPMORGAN ASIA GROWTH & INCOME PLC (the 'Company') Legal Entity Identifier: 5493006R74BNJSJKCB17 THE COMPANY ANNOUNCES THE UNAUDITED...
JPMorgan Asia Growth & Income PLC 30 July 2024 JPMORGAN ASIA GROWTH & INCOME PLC (the 'Company') Legal Entity Identifier: 5493006R74BNJSJKCB17 THE COMPANY ANNOUNCES THE UNAUDITED...
JPMorgan Asia Growth & Income PLC 29 July 2024 LONDON STOCK EXCHANGE ANNOUNCEMENT JPMORGAN ASIA GROWTH & INCOME PLC (the 'Company') REPURCHASE OF ORDINARY SHARES INTO...
JPMorgan Asia Growth & Income PLC 29 July 2024 JPMORGAN ASIA GROWTH & INCOME PLC (the 'Company') Legal Entity Identifier: 5493006R74BNJSJKCB17 THE COMPANY ANNOUNCES THE INDICATIVE...
JPMorgan Asia Growth & Income PLC 29 July 2024 JPMORGAN ASIA GROWTH & INCOME PLC (the 'Company') Legal Entity Identifier: 5493006R74BNJSJKCB17 THE COMPANY ANNOUNCES THE UNAUDITED...
JPMorgan Asia Growth & Income PLC 26 July 2024 JPMORGAN ASIA GROWTH & INCOME PLC (the 'Company') Legal Entity Identifier: 5493006R74BNJSJKCB17 THE COMPANY ANNOUNCES THE UNAUDITED...
JPMorgan Asia Growth & Income PLC 25 July 2024 LONDON STOCK EXCHANGE ANNOUNCEMENT JPMORGAN ASIA GROWTH & INCOME PLC (the 'Company') REPURCHASE OF ORDINARY SHARES INTO...
JPMorgan Asia Growth & Income PLC 25 July 2024 JPMORGAN ASIA GROWTH & INCOME PLC (the 'Company') Legal Entity Identifier: 5493006R74BNJSJKCB17 THE COMPANY ANNOUNCES THE UNAUDITED...
JPMorgan Asia Growth & Income PLC 24 July 2024 JPMORGAN ASIA GROWTH & INCOME PLC (the 'Company') Legal Entity Identifier: 5493006R74BNJSJKCB17 THE COMPANY ANNOUNCES THE UNAUDITED...
JPMorgan Asia Growth & Income PLC 23 July 2024 LONDON STOCK EXCHANGE ANNOUNCEMENT JPMORGAN ASIA GROWTH & INCOME PLC (the 'Company') REPURCHASE OF ORDINARY SHARES INTO...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.